What is the appropriate antibiotic regimen for preseptal cellulitis in adults and children, including MRSA coverage?

Antibiotic Treatment for Preseptal Cellulitis

For preseptal cellulitis in children and adults, use oral cephalexin (or ampicillin-sulbactam plus clindamycin for hospitalized cases) as first-line therapy, reserving MRSA-active agents like clindamycin or vancomycin only for cases with documented MRSA risk factors or treatment failure.

Treatment Algorithm

Outpatient Management (Mild Cases)

• First-line: Oral cephalexin for 7 days
  • Targets the most common pathogens: Staphylococcus aureus and Streptococcus pyogenes 1
  • Alternative: Cefadroxil or cefprozil (once-daily dosing, better tolerability but more expensive) 1
  • For penicillin allergy: Erythromycin or azithromycin (3-day course) 1

Inpatient Management (Moderate-to-Severe Cases)

• First-line: IV ampicillin-sulbactam + clindamycin
  • This combination was used in 77.2% of hospitalized pediatric cases 2
  • Also commonly used: ceftriaxone (54.4%) + clindamycin (72.8%) 3
  • Alternative for once-daily dosing: IV ceftriaxone alone (suitable for outpatient parenteral therapy) 1

MRSA Coverage - When to Add

Do NOT routinely cover MRSA. Recent evidence shows significant overuse of MRSA-active antibiotics:

• Post-guideline implementation reduced MRSA-active agent use from 86% to 26% without adverse outcomes 4
• Broad-spectrum use decreased from 100% to 66% safely 4

Add MRSA coverage (vancomycin or clindamycin) ONLY if:

• Known MRSA colonization or prior MRSA infection
• Failure to improve after 48-72 hours of standard therapy
• Severe systemic toxicity at presentation
• Culture-proven MRSA (8.6% of orbital cellulitis cases) 5

Key Clinical Pitfalls

Avoid Overtreatment

The most common error is excessive use of dual/triple therapy and routine MRSA coverage. Implementation of evidence-based guidelines reduced:

• Dual/triple therapy from 47% to 16% 4
• Blood cultures from 32% to 18% 4
• Complete blood counts from 75% to 57% 4

Duration of Therapy

• Standard duration: 7 days (no evidence that 10 days is superior) 1
• Mean treatment duration in hospitalized children: 8.4 days 2
• Clinical improvement typically occurs by day 5 2
• Patients with leukocytosis may require longer treatment (9.3 vs 7.8 days) 2

Distinguishing from Orbital Cellulitis

Preseptal cellulitis does NOT require the aggressive management outlined in the necrotizing fasciitis guideline 6. The guideline evidence provided addresses necrotizing infections, which is a completely different entity requiring urgent surgical debridement and broad polymicrobial coverage.

Red flags suggesting orbital (not preseptal) cellulitis:

• Proptosis, ophthalmoplegia, or vision changes
• Pain with eye movement
• Requires CT/MRI imaging and often surgical intervention (>80% of orbital cases) 5

Pediatric-Specific Considerations

Dosing for children:

• Cephalexin: Standard pediatric dosing
• Clindamycin: 10-13 mg/kg/dose every 8 hours IV 6
• Ceftriaxone: 50 mg/kg/dose every 6 hours IV 6
• Vancomycin (if needed): 15 mg/kg/dose every 6 hours IV 6

Age matters: Children under 5 years show faster clinical improvement (4.4 vs 5.6 days) compared to older children 2, likely due to different immune responses and pathogen profiles.

Cost-Effectiveness Note

Surgical intervention significantly increases costs (¥13,317 vs ¥1,843) 5, making appropriate antibiotic selection crucial to avoid treatment failure requiring drainage procedures. The shift away from routine broad-spectrum antibiotics represents both better antimicrobial stewardship and cost savings 4.